Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Growth factor-mediated tissue repair" is not a single molecule or receptor, but rather describes a complex biological process in which various growth factors—such as fibroblast growth factors (FGFs), epidermal growth factor (EGF), platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and transforming growth factor-beta (TGF-beta)—coordinate the cellular events required for tissue healing after injury. These proteins bind to their respective cell surface receptors and activate intracellular signaling pathways that regulate cell migration, proliferation, differentiation, angiogenesis, extracellular matrix production, and remodeling. The interplay among different types of cells—including macrophages, fibroblasts, endothelial cells—and multiple signaling molecules ensures effective wound closure and restoration of tissue integrity. Dysregulation of these pathways can contribute to pathological conditions such as chronic wounds when underactive or fibrosis/cancer when overactive. Therapeutic strategies often target individual components within this network rather than the entire "growth factor-mediated" process itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth factor-mediated tissue repair.